Daxor Corporation (DXR) vs Harvard Bioscience, Inc. (HBIO)

Daxor Corporation and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Daxor Corporation is the larger, with a market value of $66.5M against $36.5M — 1.8× the size. Harvard Bioscience, Inc. has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 5.1×. Harvard Bioscience, Inc. grew revenue faster over the last twelve months: −1.06% against −52.1%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −251.9%) and the lower return on invested capital (−0.41% vs 0.00%). Across the 17 metrics below, Daxor Corporation leads on 12 and Harvard Bioscience, Inc. on 5.